Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease

No abstract is available for this paper.

• Publication year

  2002

• Venue

  European Journal of Pediatrics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00431-002-1000-2PMID 12373568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The long-term outcome of patients with glycogen storage disease type Ia

  2005cited by this paper
• Glycogen storage disease I and hepatocellular tumours

  2005cited by this paper
• Type I glycogen storage disease: Nine years of management with cornstarch

  2005cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Decreased urinary citrate excretion in type 1a glycogen storage disease.

  2001cited by this paper
• Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.

  1999cited by this paper
• Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease.

  1997cited by this paper
• Glycogen Storage Disease in Adults

  1994cited by this paper
• Biochemical evidence for the requirement of continuous glucose therapy in young adults with type 1 glycogen storage disease

  1994cited by this paper
• Optimal daytime feeding regimen to prevent postprandial hypoglycemia in type 1 glycogen storage disease.

  1992cited by this paper
• Continuous glucose for treatment of patients with type 1 glycogen-storage disease: comparison of the effects of dextrose and uncooked cornstarch on biochemical variables.

  1990cited by this paper
• Glucose therapy for glycogenosis type 1 in infants: comparison of intermittent uncooked cornstarch and continuous overnight glucose feedings.

  1990cited by this paper
• Physical growth and development of children with type 1 glycogen-storage disease: comparison of the effects of long-term use of dextrose and uncooked cornstarch.

  1990cited by this paper
• Hepatocellular carcinoma in type I glycogen storage disease

  1988cited by this paper
• Complex carbohydrates in the dietary management of patients with glycogenosis caused by glucose-6-phosphatase deficiency.

  1988cited by this paper
• Type 1a glycogen storage disease with hepatoblastoma in siblings

  1987cited by this paper
• Optimal rate of enteral glucose administration in children with glycogen storage disease type I.

  1986cited by this paper
• The Dietary Treatment of Children with Type I Glycogen Storage Disease with Slow Release Carbohydrate

  1984cited by this paper
• Cornstarch therapy in type I glycogen-storage disease.

  1984cited by this paper
• Intragastric Feeding in Type I Glycogen Storage Disease: Factors Affecting the Control of Lactic Acidemia

  1981cited by this paper
• Type I glycogen storage disease: five years of management with nocturnal intragastric feeding.

  1980cited by this paper
• Type I glycogen storage disease: a metabolic basis for advances in treatment.

  1979cited by this paper
• Nocturnal Gastric Drip Feeding in Glucose-6-Phosphatase Deficient Children

  1979cited by this paper
• Type I glycogen storage disease: a metabolic basis for advances in treatment.

  1979cited by this paper
• Measurement of “True” Glucose Production Rates in Infancy and Childhood with 6,6-Dideuteroglucose

  1977cited by this paper
• Glycogen storage disease: new approaches to therapy.

  1977cited by this paper
• Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.

  1976cited by this paper
• Growth in glycogen-storage disease type 1. Evaluation of endocrine function.

  1969cited by this paper
• Glycogen disease of the liver (von Gierke's disease) with hepatomata; case report with metabolic studies.

  1955cited by this paper

• Understanding Glycogen Storage Disease Type IX: A Systematic Review with Clinical Focus—Why It Is Not Benign and Requires Vigilance

  2025cites this paper
• Kidney involvement in glycogen storage disease type I: Current knowledge and key challenges.

  2025cites this paper
• Glycogen Storage Disease Type Ia: A Retrospective Claims Analysis of Complications, Resource Utilization, and Cost of Care

  2025cites this paper
• Clinical, laboratory and molecular features of glycogen storage disease type 1a and 1b patients from Turkey: novel mutations and phenotypes

  2025cites this paper
• Safety and Efficacy of DTX401, an AAV8‐Mediated Liver‐Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a (GSDIa)

  2025cites this paper
• Evaluation of continuous glucose monitoring and nutritional status in glycogen storage diseases

  2025cites this paper
• Glucose dynamics in glycogen storage disease type IXa with novel PHKA2 variants: insights from our experience and a comprehensive review of the disease spectrum

  2025cites this paper
• Short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study

  2024cites this paper
• Olfactory and gustatory perception in Brazilian PKU patients: A cross‐sectional study

  2024cites this paper
• Diagnosing glycogen storage disease type 1b in adulthood: A case with multiple hepatocellular adenomas

  2024cites this paper
• Nutritional support in glycogen storage diseases: evolution of treatment and unresolved contradictions

  2023cites this paper
• Clinical and biochemical footprints of inherited metabolic diseases. XIV. Metabolic kidney diseases

  2023cites this paper
• A homozygous variant in G6PC in a Vietnamese patient with glycogen storage disease type Ia

  2022cites this paper
• Prevalence and Complications of Glycogen Storage Disease in South Korea: A Nationwide Population-Based Study, 2007-2018

  2022cites this paper
• Development of minimally invasive 13C-glucose breath test to examine different exogenous carbohydrate sources in patients with glycogen storage disease type Ia

  2022cites this paper
• Multidisciplinary management of pregnancy and labour in a patient with glycogen storage disease type 1a

  2021cites this paper
• Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia

  2021cites this paper
• Uncooked cornstarch for the prevention of hypoglycemic events

  2021cites this paper
• Clinical, Biochemical and Molecular Characterization of a Cohort of Glycogen Storage Disease Type I Patients in a High Complexity Hospital in Argentina

  2021cites this paper
• Hypoglycemia in the Toddler and Child

  2021cites this paper
• Modifiable factors affecting renal preservation in type I glycogen storage disease after liver transplantation: a single-center propensity-match cohort study

  2021cites this paper
• A case report of acute pancreatitis with glycogen storage disease type IA in an adult patient and review of the literature

  2020cites this paper
• Hepatic glycogen storage diseases are associated to microbial dysbiosis

  2019cites this paper
• Metabolomic analysis reveals metabolic characteristics of children with short stature caused by growth hormone deficiency.

  2019cites this paper
• Feeding Difficulties and Orofacial Myofunctional Disorder in Patients with Hepatic Glycogen Storage Diseases.

  2019influential citation
• General Discussion and Future Perspectives

  2019cites this paper
• Development of Hepatocellular Carcinoma in Patients with Glycogen Storage Disease: a Single Center Retrospective Study

  2019cites this paper
• Metabolic Control, Quality of Life, and Body Image in Patients with Glycogen Storage Disease Type Ia

  2019cites this paper
• Dietary Management of the Glycogen Storage Diseases: Evolution of Treatment and Ongoing Controversies.

  2019influential citation
• Dynamics of clinical and laboratory indices in children with glycogen storage disease type I on comprehensive therapy

  2019cites this paper
• Acute psychosis in glycogen storage disease: a rare but severe complication

  2019cites this paper
• Hepatic glycogen storage diseases: pathogenesis, clinical symptoms and therapeutic management

  2019cites this paper
• Dificuldade alimentar, distúrbio miofuncional orofacial e sentidos químicos em pacientes com glicogenose hepática

  2018cites this paper
• Inborn Errors of Metabolism with Hypoglycemia: Glycogen Storage Diseases and Inherited Disorders of Gluconeogenesis.

  2018cites this paper
• The Physiopathological Role of the Exchangers Belonging to the SLC37 Family

  2018cites this paper
• Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia

  2018cites this paper
• Glycogen Storage Disease Ib and Severe Periodontal Destruction: A Case Report

  2018cites this paper
• Inborn Errors of Metabolism with Hypoglycemia Glycogen Storage Diseases and Inherited Disorders of Gluconeogenesis

  2018cites this paper
• Metabolic adaptations in models of fatty liver disease Hijmans

  2017cites this paper
• Combined Liver Kidney Transplantation in Pediatrics : Indications , Special Considerations , and Outcomes

  2017cites this paper
• Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy

  2017cites this paper
• Inflammatory Bowel Disease in Glycogen Storage Disease Type Ia

  2017cites this paper
• Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control

  2017cites this paper
• Metabolic adaptations in models of fatty liver disease: Of mice and math

  2017cites this paper
• Sleep and quality of life of patients with glycogen storage disease on standard and modified uncooked cornstarch.

  2017cites this paper
• 39 – Diseases Associated with Primary Abnormalities in Carbohydrate Metabolism

  2017cites this paper
• Nutritional Status and Body Composition in Patients With Hepatic Glycogen Storage Diseases Treated With Uncooked Cornstarch—A Controlled Study:

  2017cites this paper
• JIMD Reports, Volume 26

  2016cites this paper
• Rapid height growth after liver transplantation in adulthood.

  2016cites this paper
• Evaluation of central nervous system in patients with glycogen storage disease type 1a.

  2016cites this paper
• Tophaceous gout in a female premenopausal patient with an unexpected diagnosis of glycogen storage disease type Ia: a case report and literature review

  2016cites this paper
• Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study

  2015cites this paper
• The effect of tailoring of cornstarch intake on stature in children with glycogen storage disease type III

  2015cites this paper
• Safety and Efficacy of Chronic Extended Release Cornstarch Therapy for Glycogen Storage Disease Type I.

  2015cites this paper
• A pilot longitudinal study of the use of waxy maize heat modified starch in the treatment of adults with glycogen storage disease type I: a randomized double-blind cross-over study

  2015cites this paper
• Glicogenoses hepáticas : estudo do uso de diferentes amidos e caracterização do perfil de parâmetros do metabolismo do ferro

  2015cites this paper
• METABOLIČKE BOLESTI JETRE

  2015cites this paper
• Metaboličke bolesti jetre

  2015cites this paper
• Renal manifestations of metabolic disorders in children

  2015cites this paper
• Regression of hepatocellular adenomas with strict dietary therapy in patients with glycogen storage disease type I.

  2015cites this paper
• Disordered Eating and Body Esteem Among Individuals with Glycogen Storage Disease.

  2015cites this paper
• In vitro digestion of starches in a dynamic gastrointestinal model: an innovative study to optimize dietary management of patients with hepatic glycogen storage diseases

  2015cites this paper
• Multiple phenotypes in phosphoglucomutase 1 deficiency.

  2014cites this paper
• lycogen storage disease type I : clinical and laboratory

  2014cites this paper
• Multiple Phenotypes in Phosphoglucomutase 1 Deficiency

  2014cites this paper
• Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers

  2014cites this paper
• Pregnancy in Women With Glycogen Storage Disease Ia and Ib

  2014cites this paper
• Glycogen storage disease type I: clinical and laboratory profile.

  2014cites this paper
• Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics

  2014cites this paper
• Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy.

  2014cites this paper
• Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia.

  2013cites this paper
• Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis.

  2013cites this paper
• anemia: implications for the anemia of chronic disease Inappropriate expression of hepcidin is associated with iron refractory

  2013cites this paper
• The role of Dmt1 in the copper-related compensatory response of the intestinal epithelium during iron deficiency

  2013cites this paper
• Aggressive therapy improves cirrhosis in glycogen storage disease type IX.

  2013cites this paper
• Management of intentional overdose of insulin glargine.

  2012cites this paper
• Bone mineral density in glycogen storage disease type Ia and Ib

  2012cites this paper
• Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib

  2012cites this paper
• Clinical Outcome of Hepatocyte Transplantation in Four Pediatric Patients with Inherited Metabolic Diseases

  2012cites this paper
• This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. Medical Management of Chronic Liver Diseases in Children (Part I) Focus on Curable or Potentially Curable Diseases

  2011cites this paper
• Medical Management of Chronic Liver Diseases (CLD) in Children (Part II)

  2011cites this paper
• Treatment strategies for acute metabolic disorders in neonates.

  2011cites this paper
• Medical Management of Chronic Liver Diseases in Children (Part I)

  2011cites this paper
• Glucose-6-phosphatase deficiency

  2011cites this paper
• Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports.

  2011cites this paper
• Natural history of hepatocellular adenoma formation in glycogen storage disease type I.

  2011cites this paper
• Dietary dilemmas in the management of glycogen storage disease type I

  2011cites this paper
• Glycogen Storage Disease Type Ia in Canines: A Model for Human Metabolic and Genetic Liver Disease

  2011cites this paper
• Improvement of the nutritional management of glycogen storage disease type I

  2010cites this paper
• Early diagnosis and treatment may prevent the development of complications in an adult patient with glycogen storage disease type Ia.

  2010cites this paper
• Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy

  2010cites this paper
• Obesity and Reversed Growth Retardation in a Child with Type Ia Glycogen Storage Disease

  2010influential citation
• Early Diagnosis and Treatment may Prevent the Development of Complications in an Adult Patient with Glycogen Storage Disease Type Ιa

  2010cites this paper
• Glicogenose Tipo I Disfunção do Complexo Glicose-6-fosfátase

  2009cites this paper
• Liver transplantation for glycogen storage disease type Ia.

  2009cites this paper
• Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease.

  2008cites this paper
• Iron homeostasis and erythropoiesis.

  2008cites this paper
• Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib.

  2008cites this paper
• Nutritional Therapy for Glycogen Storage Diseases

  2008cites this paper
• Mutations in the glucose‐6‐phosphatase‐α (G6PC) gene that cause type Ia glycogen storage disease

  2008cites this paper